|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.436
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.400
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.308
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.282
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.263
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.234
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.211
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.210
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.204
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.201
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.197
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.194
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.189
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.166
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.158
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.148
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.143
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.132
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.130
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.129
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.128
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.128
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.121
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.115
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.107
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.106
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.105
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.104
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.104
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.100
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.094
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.094
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.093
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.093
|
|
|
naphthalene containing compound metabolic process
|
GO:0090420 |
1 |
0.089
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.088
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.086
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.083
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.081
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.081
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.080
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.078
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.078
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.078
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.078
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.076
|
|
|
positive regulation of steroid hormone secretion
|
GO:2000833 |
2 |
0.076
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.076
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.076
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.076
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.075
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.074
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.073
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.072
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.072
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.071
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.070
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.065
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.065
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.064
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.064
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.064
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.064
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.063
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.061
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.061
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.060
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.059
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.059
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.058
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.058
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.057
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.056
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.054
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.054
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.053
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.053
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.052
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.052
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.052
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.050
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.050
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.049
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.048
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.048
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.047
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.047
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.047
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.047
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.047
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.046
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.046
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.046
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.046
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.046
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.046
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.045
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.045
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.045
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.045
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.044
|
|
|
directional locomotion
|
GO:0033058 |
3 |
0.044
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.044
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.044
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.044
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.044
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.044
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.043
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.043
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.043
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.042
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.042
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.041
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.041
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.041
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.041
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.040
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.040
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.040
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.040
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.040
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.040
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.040
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.039
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.039
|
|
|
glial cell apoptotic process
|
GO:0034349 |
3 |
0.039
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.039
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.039
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.039
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.039
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.039
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.038
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.038
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.038
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.038
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.038
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.037
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.037
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.037
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.037
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.037
|
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
11 |
0.036
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.036
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.036
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.036
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.036
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.035
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.035
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.035
|
|
|
regulation of vitamin d biosynthetic process
|
GO:0060556 |
1 |
0.035
|
|
|
diacylglycerol biosynthetic process
|
GO:0006651 |
2 |
0.035
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.035
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.035
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.035
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
4 |
0.035
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.034
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.034
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.034
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.034
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.034
|
|
|
regulation of glutamate metabolic process
|
GO:2000211 |
1 |
0.034
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.033
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.033
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.033
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.033
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.033
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.033
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.033
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.033
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.033
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.032
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.032
|
|
|
keratinocyte migration
|
GO:0051546 |
3 |
0.032
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.032
|
|
|
circadian temperature homeostasis
|
GO:0060086 |
2 |
0.032
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.032
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.032
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.031
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.031
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.031
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.031
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.031
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.031
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.031
|
|
|
regulation of interleukin 5 secretion
|
GO:2000662 |
2 |
0.031
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.031
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.031
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.031
|
|
|
myelination
|
GO:0042552 |
74 |
0.031
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.031
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.031
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.031
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.030
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.030
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.030
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.030
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.030
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.029
|
|
|
cellularization
|
GO:0007349 |
1 |
0.029
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.029
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.029
|
|
|
negative regulation of interleukin 13 secretion
|
GO:2000666 |
1 |
0.029
|
|
|
l alpha amino acid transmembrane transport
|
GO:1902475 |
23 |
0.029
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.029
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.029
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.029
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.029
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.029
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.029
|
|
|
interleukin 5 secretion
|
GO:0072603 |
2 |
0.028
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.028
|
|
|
regulation of nitrogen cycle metabolic process
|
GO:1903314 |
1 |
0.028
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.028
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.028
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.028
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.028
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.028
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.028
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.027
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.027
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.027
|
|
|
positive regulation of lipid transport
|
GO:0032370 |
22 |
0.027
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.027
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.027
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.027
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.027
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.027
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.026
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.026
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.026
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.026
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.026
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.026
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.026
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.026
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.026
|
|
|
regulation of interleukin 13 secretion
|
GO:2000665 |
2 |
0.026
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.025
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.025
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.025
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.025
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.025
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.025
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.025
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.025
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.025
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.024
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.024
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.024
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.024
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.024
|
|
|
methylation
|
GO:0032259 |
134 |
0.024
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.024
|
|
|
protein processing
|
GO:0016485 |
163 |
0.024
|
|
|
anion transport
|
GO:0006820 |
177 |
0.024
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
26 |
0.024
|
|
|
tetrapyrrole metabolic process
|
GO:0033013 |
22 |
0.024
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.024
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.024
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.024
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.024
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.024
|
|
|
lung development
|
GO:0030324 |
164 |
0.024
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.024
|
|
|
kidney development
|
GO:0001822 |
213 |
0.024
|
|
|
positive regulation of protein ubiquitination
|
GO:0031398 |
27 |
0.023
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.023
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.023
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.023
|
|
|
regulation of brown fat cell proliferation
|
GO:0070347 |
1 |
0.023
|
|
|
regulation of ammonia assimilation cycle
|
GO:2001248 |
1 |
0.023
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.023
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.023
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.023
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.023
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.023
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.023
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.023
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.023
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.023
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.023
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.022
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.022
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.022
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.022
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.022
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.022
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.022
|
|
|
naphthalene metabolic process
|
GO:0018931 |
1 |
0.022
|
|
|
cation transport
|
GO:0006812 |
399 |
0.022
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.022
|
|
|
response to bile acid
|
GO:1903412 |
1 |
0.022
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.022
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.022
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.022
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.022
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.022
|
|
|
linoleic acid metabolic process
|
GO:0043651 |
6 |
0.022
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.021
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.021
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.021
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.021
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.021
|
|
|
wound healing
|
GO:0042060 |
157 |
0.021
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.021
|
|
|
establishment of protein localization to vacuole
|
GO:0072666 |
4 |
0.021
|
|
|
regulation of interleukin 1 alpha secretion
|
GO:0050705 |
3 |
0.021
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.021
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.021
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.021
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.021
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.021
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.021
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.021
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.021
|
|
|
brown fat cell proliferation
|
GO:0070342 |
1 |
0.021
|
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.021
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.021
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.021
|
|
|
coagulation
|
GO:0050817 |
78 |
0.020
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.020
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.020
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.020
|
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
38 |
0.020
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.020
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.020
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.020
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.020
|
|
|
skin development
|
GO:0043588 |
220 |
0.020
|
|
|
ammonia assimilation cycle
|
GO:0019676 |
2 |
0.020
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.020
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.020
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.020
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.020
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.019
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.019
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.019
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.019
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.019
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.019
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.019
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.019
|
|
|
negative regulation of interleukin 5 secretion
|
GO:2000663 |
1 |
0.019
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.019
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.019
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.019
|
|
|
glucose catabolic process
|
GO:0006007 |
3 |
0.019
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.019
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.019
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.019
|
|
|
b cell apoptotic process
|
GO:0001783 |
19 |
0.019
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.019
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.019
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.019
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.019
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.018
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.018
|
|
|
porphyrin containing compound metabolic process
|
GO:0006778 |
22 |
0.018
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.018
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.018
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.018
|
|
|
action potential
|
GO:0001508 |
78 |
0.018
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.018
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.018
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.018
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.018
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.018
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.018
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.018
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.018
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.018
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.018
|
|
|
negative regulation of interleukin 13 production
|
GO:0032696 |
2 |
0.018
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.018
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.018
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.017
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.017
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.017
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.017
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.017
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.017
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.017
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.017
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.017
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.017
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.017
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.017
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.017
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.017
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.017
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.017
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.017
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.017
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.017
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.017
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.017
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.017
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.017
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.017
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.017
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.017
|
|
|
response to uv
|
GO:0009411 |
44 |
0.017
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.016
|
|
|
gonad development
|
GO:0008406 |
141 |
0.016
|
|
|
hexose catabolic process
|
GO:0019320 |
3 |
0.016
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.016
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.016
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.016
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.016
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.016
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.016
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.016
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.016
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.016
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.016
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.016
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.016
|
|
|
apoptotic process involved in mammary gland involution
|
GO:0060057 |
4 |
0.016
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.016
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.016
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.016
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.016
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.016
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.016
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.016
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.016
|
|
|
glucan metabolic process
|
GO:0044042 |
32 |
0.016
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.016
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.016
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.016
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.016
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.016
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.016
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.016
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.016
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.016
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.016
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.015
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.015
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.015
|
|
|
negative regulation of fat cell proliferation
|
GO:0070345 |
2 |
0.015
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.015
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.015
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.015
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.015
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.015
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.015
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.015
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.015
|
|
|
gland development
|
GO:0048732 |
330 |
0.015
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.015
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.015
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.015
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.015
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.015
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.015
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.015
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.015
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.015
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.015
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.015
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.015
|
|
|
xenobiotic catabolic process
|
GO:0042178 |
1 |
0.015
|
|
|
amide transport
|
GO:0042886 |
138 |
0.015
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.015
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.015
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001267 |
4 |
0.015
|
|
|
positive regulation of amino acid transport
|
GO:0051957 |
4 |
0.015
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.014
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.014
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.014
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.014
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.014
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.014
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.014
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.014
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.014
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.014
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.014
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.014
|
|